PTX — Prescient Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapHigh Flyer

Annual balance sheet for Prescient Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	7.38	16.1	12.3	21.9	14.5
Net Total Accounts Receivable
Net Total Receivables	1.06	1.24	1.72	2.58	3.92
Prepaid Expenses
Total Current Assets	8.71	17.6	14.2	24.7	18.7
Net Property, Plant And Equipment	0	0.002	0.005	0.003	0.002
Net Intangible Assets
Total Assets	12.1	21	17.6	28.1	20.4
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.864	0.515	0.809	2.03	2.32
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.884	0.54	0.856	2.03	2.33
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	11.2	20.4	16.8	26.1	18.1
Total Liabilities & Shareholders' Equity	12.1	21	17.6	28.1	20.4
Total Common Shares Outstanding